Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Pfizer Inc (PFE) vs TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock (TTWO) Price & Performance

Pfizer IncTrade
TAKE-TWO INTERACTIVE SOFTWARE, INC Common StockTrade

Price performance (Past 24H)

Key statistics

Pfizer Inc vs TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock — how do they compare? Pfizer Inc trades at $24.89 (market cap $142.14B), while TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock trades at $233.23 (market cap $43.80B). The key difference: Pfizer Inc is far larger — about 3.2× TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock's market cap, and Pfizer Inc pays a 6.9% dividend while TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock pays none. Which is the better fit depends on your goals.

PFETTWO
Market Cap
$142.14B$43.80B
Volume
29,869,932
Sector
HealthMedia
52-Week High
$28.56$262.29
52-Week Low
$23.29$189.69
Enterprise Value
$192.80B$44.77B
Dividend Yield
6.9%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Pfizer Inc

Pfizer (PFE) trades at $24.75, down 1.2% on the day, with a neutral technical outlook. The company maintains strong fundamentals with consistent earnings beats, including Q1 2026 EPS of $0.75 beating expectations of $0.722. Pfizer demonstrates robust profitability with a 73.51% gross margin and 11.83% net income margin, though revenue has moderated from pandemic peaks. Recent news highlights the company's focus on AI drug discovery and pipeline development.

Pfizer presents a value opportunity trading below analyst consensus target of $28.25, with 38% of analysts rating it Buy. The stock offers a solid dividend yield with recent $0.43 payments. Key risks include patent expirations and revenue normalization post-COVID, while catalysts include obesity and oncology pipeline developments in 2026.

TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock

Take-Two Interactive (TTWO) trades at $235.93, down 0.31% on the day, with a neutral technical signal despite recent earnings beats. The company shows strong revenue growth to $5.63 billion in 2025 but faces profitability challenges with a net income margin of -4.48%. Analyst sentiment remains overwhelmingly positive with a 78.95% buy rating and a consensus price target of $302.50, driven by anticipation for Grand Theft Auto VI.

The outlook hinges on GTA VI execution, with potential for significant upside if launch succeeds, but risks include persistent negative cash flow from operations and high debt levels. Investors should weigh strong analyst confidence against fundamental weaknesses in profitability and cash generation.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Pfizer Inc

Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.

Read more on PFE

About TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock

Found in 1993, Take-Two consists of three wholly owned labels, Rockstar Games, 2K, and Zynga. The firm is one of the world's largest independent video game publishers on consoles, PCs, smartphones, and tablets. Take-Two's franchise portfolio is headlined by Grand Theft Auto (345 million units sold) and contains other well-known titles such as NBA 2K, Civilization, Borderlands, Bioshock, and Xcom. Zynga mobile titles include Farmville, Empires & Puzzles, and CSR Racing.

Read more on TTWO